Neuroendocrine tumors of the female reproductive tract are a heterogeneous group of neoplasms that display various histologic findings and biologic behaviors. In this review, the classification and clinicopathologic characteristics of neuroendocrine tumors of the female reproductive tract are described. Differential diagnoses are discussed, especially for non-neuroendocrine tumors showing high-grade nuclei with neuroendocrine differentiation. This review also discusses recent advances in our pathogenetic understanding of these disorders.
Citations
Citations to this article as recorded by
Diagnostic and therapeutic challenge of neuroendocrine endometrial carcinoma: a case report Hariyono Winarto, David Calvin, Fitriyadi Kusuma, Kartiwa Hadi Nuryanto, Yuri Feharsal, Dewita Nilasari, Hartono Tjahjadi The Pan African Medical Journal.2024;[Epub] CrossRef
Neuroendocrine carcinoma of ovary: Hitherto rare entity in primary ovarian tumors Md A. Osama, Seema Rao, Punita Bhardwaj, Geeta Mediratta, Sunita Bhalla, Sonia Badwal Indian Journal of Pathology and Microbiology.2023; 66(4): 855. CrossRef
Mixed neuroendocrine–non-neuroendocrine neoplasm with mucinous adenocarcinoma and amphicrine carcinoma components in the bile duct: an autopsy case Toji Murabayashi, Yoshihide Kanno, Takashi Odaira, Shinsuke Koshita, Takahisa Ogawa, Hiroaki Kusunose, Toshitaka Sakai, Keisuke Yonamine, Kazuaki Miyamoto, Fumisato Kozakai, Kazuki Endo, Yutaka Noda, Takashi Sawai, Kei Ito Clinical Journal of Gastroenterology.2023; 16(2): 310. CrossRef
Coexistence of Papillary Thyroid Carcinoma and Strumal Carcinoid Arising from Struma Ovarii in Pregnant Women: a Case Report and Review Myungsoo Im, Doohwa Kim, Soree Ryang, Bo Hyun Kim International Journal of Thyroidology.2023; 16(1): 134. CrossRef
Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases Michaela Kendall Bártů, Kristýna Němejcová, Romana Michálková, Quang Hiep Bui, Jana Drozenová, Pavel Fabian, Oluwole Fadare, Jitka Hausnerová, Jan Laco, Radoslav Matěj, Gábor Méhes, Adam Šafanda, Naveena Singh, Petr Škapa, Zuzana Špůrková, Simona Stolnicu International Journal of Gynecological Pathology.2023;[Epub] CrossRef
Role of radiotherapy in the management of rare gynaecological cancers R. Morcet-Delattre, S. Espenel, P. Tas, C. Chargari, A. Escande Cancer/Radiothérapie.2023; 27(8): 778. CrossRef
Small cell carcinoma of the ovary, pulmonary type: A role for adjuvant radiotherapy after carboplatin and etoposide? Anase S. Asom, Ricardo R. Lastra, Yasmin Hasan, Lori Weinberg, Gini F. Fleming, Katherine C. Kurnit Gynecologic Oncology Reports.2022; 39: 100925. CrossRef
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer Stefano Miglietta, Giulia Girolimetti, Lorena Marchio, Manuela Sollazzo, Noemi Laprovitera, Sara Coluccelli, Dario De Biase, Antonio De Leo, Donatella Santini, Ivana Kurelac, Luisa Iommarini, Anna Ghelli, Davide Campana, Manuela Ferracin, Anna Myriam Perr Non-Coding RNA.2022; 8(5): 64. CrossRef
Neuroendocrine Carcinomas of the Uterine Cervix, Endometrium, and Ovary Show Higher Tendencies for Bone, Brain, and Liver Organotrophic Metastases Hyung Kyu Park Current Oncology.2022; 29(10): 7461. CrossRef
Uterine carcinoma admixed with neuroendocrine carcinoma Maria Victoria Olinca, Anca Potecă, Elvira Brătilă, Mihai Mitran Ginecologia.ro.2022; 4(38): 32. CrossRef
The puzzle of gynecologic neuroendocrine carcinomas: State of the art and future directions Giuseppe Caruso, Carolina Maria Sassu, Federica Tomao, Violante Di Donato, Giorgia Perniola, Margherita Fischetti, Pierluigi Benedetti Panici, Innocenza Palaia Critical Reviews in Oncology/Hematology.2021; 162: 103344. CrossRef
Pitfalls and challenges in managing neuroendocrine carcinoma of gynecological origin: A case series and brief review Lauren E. Farmer, Rutmi U. Goradia, Nisha A. Lakhi Clinical Case Reports.2021;[Epub] CrossRef
Primary mixed large cell neuroendocrine and high grade serous carcinoma of the endometrium Liesel Elisabeth Hardy, Zia Chaudry, King Wan, Chloe Ayres BMJ Case Reports.2020; 13(9): e234977. CrossRef
Neuroendocrine carcinoma of the endometrium: Disease course, treatment, and outcomes Kathryn Schlechtweg, Ling Chen, Caryn M. St. Clair, Ana I. Tergas, Fady Khoury-Collado, June Y. Hou, Alexander Melamed, Alfred I. Neugut, Dawn L. Hershman, Jason D. Wright Gynecologic Oncology.2019; 155(2): 254. CrossRef
Peritoneal Fluid Cytology of Disseminated Large Cell Neuroendocrine Carcinoma Combined with Endometrioid Adenocarcinoma of the Endometrium Yong-Moon Lee, Min-Kyung Yeo, Song-Yi Choi, Kyung-Hee Kim, Kwang-Sun Suh Journal of Pathology and Translational Medicine.2019; 53(6): 407. CrossRef
Pro-Gastrin Releasing Peptide: A New Serum Marker for Endometrioid Adenocarcinoma Mine Kiseli, Gamze Sinem Caglar, Asli Yarci Gursoy, Tolga Tasci, Tuba Candar, Egemen Akincioglu, Emre Goksan Pabuccu, Nurettin Boran, Gokhan Tulunay, Haldun Umudum Gynecologic and Obstetric Investigation.2018; 83(6): 540. CrossRef
Tumeur neuroendocrine à petite cellule de l’endomètre : prise en charge originale E. Galmiche, N. Hudry, P. Sagot, P. Ginod, S. Douvier Gynécologie Obstétrique Fertilité & Sénologie .2017; 45(6): 381. CrossRef
Twist on a classic: vitamin D and hypercalcaemia of malignancy Juan C Osorio, Masha G Jones, Nina Schatz-Siemers, Stephanie J Tang BMJ Case Reports.2017; : bcr-2017-220819. CrossRef
Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms Stefano La Rosa, Fausto Sessa, Silvia Uccella Endocrine Pathology.2016; 27(4): 284. CrossRef
Neuroendocrine tumours in rare sites: differences in nomenclature and diagnostics—a rare and ubiquitous histotype Elia Guadagno, Gaetano De Rosa, Marialaura Del Basso De Caro Journal of Clinical Pathology.2016; 69(7): 563. CrossRef
Primary ovarian neuroendocrine tumor arising in association with a mature cystic teratoma: A case report Nicolas M. Orsi, Mini Menon Gynecologic Oncology Reports.2016; 17: 83. CrossRef
Benign Endometrial Polyp and Primary Endometrial Small Cell Neuroendocrine Carcinoma Confined to the Polyp: A Rare Association Pembe Oltulu, Ceyhan Uğurluoğlu, Ayşenur Uğur, Sıdıka Fındık, Lema Tavlı Journal of Clinical and Experimental Investigations.2016;[Epub] CrossRef
Carcinosarcomas of the female genital tract have generally been regarded as a type of sarcoma. Recent studies, however, suggest the tumor may be more closely related to carcinoma and may represent metaplastic carcinoma in histogenesis. We analyzed clinicopathologic and immunohistochemical features of 10 carcinosarcomas to evaluate the relative importance of the carcinomatous and sarcomatous components in metastasis and recurrence. The primary tumor originated in the uterine body in seven cases, the uterine cervix in two and the ovary in one. Patient,s ages ranged from 54 to 71 years (mean, 64). The most common symptom of the uterine mass was vaginal bleeding. The median survival time was 21 months following diagnosis in five cases. Surgico-pathologic FIGO stages of five patients who received an operation were stage III and IV, but clinical FIGO stage of three patients (60%) among them were I. Lymphovascular invasions were identified in seven areas; five vascular invasion lesions showed the carcinomatous component alone, one the sarcomatous component alone, and remained one admixture of both components.
Metastatic and recurrent lesions to the paraaortic lymph node, ovary, pelvic wall, or vaginal vault showed characteristically carcinomatous component only.
Immunohistochemically, positive reactions for cytokeratin and epithelial membrane antigen were noted in the sarcomatous component of five cases. Vimentin positivity was detected in carcinomatous component of three cases. We conclude that the dominant element in carcinosarcomas of the female genital tract is the carcinomatous component. The survival rate of carcinosarcoma is extremely poor. The surgico-pathologic stage is better indicator of survival than the clinical stage. Immunohistochemical findings suggest that carcinosarcoma may represent a metaplastic carcinoma in histogenesis.
Hee Jung Lee, Young Shin Kim, Yong Gu Kim, Kyung Ja Han, Kyo Young Lee, Chang Suk Kang, Sang In Shim, Jong Wook Lee, Woong Shick Ahn, Soo Pyung Aim, Seung Il Kim
Prolymphocytic leukemia is a chronic lymphoproliferative disorder, characterized by prominent splenomegaly, prolymphocytes accounting for more than 55% of circulating lymphocytes, no significant peripheral lymphadenopathy and short term survival with terminal fatal multi-organ failure.
We report a case of B-cell prolymphocytic leukemia in a 57-year-old woman who presented with easy bruising and arthritis for 1 year and low abdominal pain for 2 months.
Physical examination revealed gingival hypertrophy and mild splenomegaly. On peripheral blood smears the leukocytes were markedly increased in number due to leukemic cells that count about 62% of leukocytes. The bone marrow aspiration smear and biopsy revealed diffuse infiltration of medium to large prolymphocytes having moderate amount of basophilic cytoplasm, round to oval nuclei with coarse chromatin, and prominent nucleoli. Abdominal pain aggravated despite chemotherapy, and pelvic computed tomography (CT) revealed a huge lobular pelvic mass which had increased in size on the follow-up CT. Total hysterectomy with bilateral adnexectomy was performed. Microscopic findings included massive infiltration of prolymphocytic cells in the uterus, upper vaginal wall, bilateral ovaries, and bilateral mesosalpinges. On immunohistochemistry, the leukemic cells showed B cell gamma light chain phenotype.
We report a case of primary osteosarcoma of the breast which is rare and exhibits poor prognosis. A 52 years-old-woman was admitted with rapidly growing right mammary mass. A huge lobulated dense mass with speckled calcifications, suggesting malignancy, was observed on mammography. She underwent a radical mastectomy. Grossly, the mass measured 16 14 6 cm and showed grayish white hard lobulated tissue with focal hemorrhage and necrosis. Light microscopically, the tumor was confirmed as an osteosarcoma devoid of any epithelial components. In postoperative whole body bone scan, there was no evidence of the other malignancy. To the best of our knowledge, the present case is the first report of primary osteosarcoma of the breast in Korea.
Cellular angiofibroma is a recently described, distinctive soft tissue tumor of the vulvovaginal region which is characterized by small, well-circumscribed tumors with fibroblastic differentiation. We report three cases of cellular angiofibroma of the vulva in middle-aged women. All three patients presented with painless swelling in the labium majora. The age of the three patients ranged from 43 to 56 years old (mean: 48 years old) and the size of the tumor ranged from 2 to 5 cm. The microscopic appearance was characterized by a cellular, well-circumscribed mass composed of uniform, bland, spindle stromal cells, numerous thick-walled, hyalinized vessels, and a scarce component of mature adipocytes. Immunohistochemical stains of the tumor cells show positivity for vimentin but negativity for smooth muscle actin, S-100 protein, desmin, factor VIII-related antigen and epithelial membrane antigen. The tumor should be differentiated from aggressive angiomyxoma and angiomyofibroblastoma because of its different clinicopathologic features, cells of origin and immunohistochemical findings.
We report a case of right broad ligament tumor with features of female adnexal tumor of probable wolffian origin. A 40-year-old woman presented with dysfunctional uterine bleeding. Ultrasonography revealed 1 10cm sized right parovarian solid mass. On microscopic examination, the tumor showed mixed pattern of tightly packed tubular structures and diffuse spindle cell proliferation. Immunohistochemical study demonstrated cytokeratin-and vimentin-positivity and carcino-embryonic antigen-negativity. The ultrastructural study showed prominent tubular structures, continuous basal lamina, definite junctional complex but no secretory granules or glycogen particles, favoring wolffian origin.